COMPARISON OF RENAL DYSFUNCTION IN SYSTOLIC HEART FAILURE PATIENTS TREATED WITH SACUBITRIL-VALSARTAN OR ACE INHIBITOR/ANGIOTENSIN RECEPTOR BLOCKER

被引：1
|
作者：
Tan, Nicholas [1 ]
Deng, Yihong [1 ]
Yao, Xiaoxi [1 ]
Sangaralingham, LIndsey [1 ]
Shah, Nilay [1 ]
Rule, Andrew [1 ]
Burnett, John [1 ]
Dunlay, Shannon [1 ]
Sangaralingham, Jeson [1 ]
机构：
[1] Mayo Clin, Rochester, MN USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2020年 / 75卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1415-77
引用
收藏
页码：1023 / 1023
页数：1
相关论文
共 50 条
  • [41] Effects of Sacubitril-Valsartan in Patients With Various Types of Heart Failure: A Meta-analysis
    Zhang, Hongyu
    Huetteman, Abigail T.
    Reyes, Eduardo A.
    Appelbaum, Jonathan S.
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2023, 81 (06) : 434 - 444
  • [42] SACUBITRIL-VALSARTAN PRESCRIPTION AND TOLERANCE AMONG INOTROPE-DEPENDENT HEART FAILURE PATIENTS
    Singh, Kerry Shastri
    Pillai, Ashwin Ajaikumar
    Shaik, Ayesha
    Fakess, Seth
    Tolat, Aneesh V.
    Mai, Xingchen
    Ali, Ayyaz A.
    Jaiswal, Abhishek
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 83 (13) : 683 - 683
  • [43] C-reactive protein reduction with sacubitril-valsartan treatment in heart failure patients
    Goncalves, Antonio Valentim
    Pereira-da-Silva, Tiago
    Galrinho, Ana
    Rio, Pedro
    Branco, Luisa Moura
    Soares, Rui
    Moreira, Rita Ilhao
    Ferreira, Rui Cruz
    AMERICAN JOURNAL OF CARDIOVASCULAR DISEASE, 2020, 10 (03): : 174 - 181
  • [44] Cost-Effectiveness of Sacubitril-Valsartan in Patients With Heart Failure With Reduced Ejection Fraction
    Sandhu, Alexander T.
    Ollendorf, Daniel A.
    Chapman, Richard H.
    Pearson, Steven D.
    Heidenreich, Paul A.
    ANNALS OF INTERNAL MEDICINE, 2016, 165 (10) : 681 - +
  • [45] Association of Heart Failure Patients With and Without Sacubitril-Valsartan Use With Incident Cancer Risk
    Hu, Wei-Syun
    Lin, Cheng-Li
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2023, 82 (02) : 157 - 161
  • [46] Anemia warrants treatment to improve survival in patients with heart failure receiving sacubitril-valsartan
    Yang, Tsun-Yu
    Lee, Chii-Ming
    Wang, Shih-Rong
    Cheng, Yu-Yang
    Weng, Shao-En
    Hsu, Wan-Tseng
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [47] Effect of the angiotensin receptor blocker valsartan on morbidity and mortality in heart failure
    Tognoni, G.
    Cohn, J. N.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2001, 15 : 111 - 111
  • [48] Entresto (Sacubitril/Valsartan): Angiotensin Receptor Neprilysin Inhibition for Treating Heart Failure
    Nicholas Phreaner
    Barry H. Greenberg
    Current Emergency and Hospital Medicine Reports, 2017, 5 (2) : 47 - 55
  • [49] Systolic Blood Pressure in Heart Failure With Preserved Ejection Fraction Treated With Sacubitril/Valsartan
    Zweiker, R.
    JOURNAL FUR HYPERTONIE, 2020, 24 (02): : 52 - 53
  • [50] Systolic Blood Pressure in Heart Failure With Preserved Ejection Fraction Treated With Sacubitril/Valsartan
    Selvaraj, Senthil
    Claggett, Brian L.
    Boehm, Michael
    Anker, Stefan D.
    Vaduganathan, Muthiah
    Zannad, Faiez
    Pieske, Burkert
    Lam, Carolyn S. P.
    Anand, Inder S.
    Shi, Victor C.
    Lefkowitz, Martin P.
    McMurray, John J. V.
    Solomon, Scott D.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (14) : 1644 - 1656
12345